Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC
Clinical trial NCT03289819 · COMPLETED
Trial details
- NCT number
- NCT03289819
- Sponsor
- Institut fuer Frauengesundheit
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-23
- Primary completion
- 2020-08-27
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.